Listed consumer sector companies in Pakistan recorded a total profit of Rs. 244 billion in 2025, showing a strong 28% increase compared to the previous year. This data comes from an analysis conducted by Topline Securities.
The study included companies from consumer staples, pharmaceuticals, and discretionary sectors, each with a market value of more than $100 million.
Overall, the net revenues of these companies increased by 14% year-on-year. This growth was mainly supported by better economic conditions and a relatively stable exchange rate, which helped businesses manage costs more effectively.
Among all sectors, pharmaceutical companies showed the highest growth. Their profits rose by 79%, reaching Rs. 36 billion.
This increase was mainly due to improved profit margins, supported by lower global costs of active pharmaceutical ingredients (APIs) and the deregulation of prices for non-essential medicines.
The discretionary sector also performed strongly, with profits increasing by 35% to Rs. 98 billion. Profit margins in this segment improved to 17.32% in 2025, compared to 15% in 2024.
This growth was driven by stable currency conditions, higher automobile sales, and the launch of new product variants.
Meanwhile, consumer staples companies reported profits of Rs. 110 billion, showing a 13% increase from the previous year.
Experts believe that this overall growth in the consumer sector reflects improving demand, better cost management, and positive business conditions across key industries in Pakistan.